Definium Therapeutics, Inc. DFTX
28.34 USD -1.14 (-3.87%)
Regular-session close
28.05 -0.29 -1.01%
After hours · Nov 20, 4:03 PM ET
28.18 Day range 29.51
10.47 52-week range 49.70
- YTD
- +111.65%
- 1 year
- +160.48%
Held by funds
104 US ETFs and mutual funds hold DFTX · largest positions
- IWM 0.14% of fund $107.63M
- VXF 0.06% of fund $57.63M
- FSSNX 0.16% of fund $56.60M
- NJM 0.07% of fund $54.77M
- VGHCX 0.13% of fund $48.25M
- IWO 0.28% of fund $38.87M
- FBIOX 0.59% of fund $35.37M
- IBB 0.29% of fund $32.19M
- FIDGX 0.35% of fund $30.96M
- VTWO 0.16% of fund $27.68M
- FGCKX 0.02% of fund $23.85M
- SCHA 0.11% of fund $23.69M
- FSMAX 0.06% of fund $23.39M
- FDSCX 0.30% of fund $22.26M
- VEXRX 0.09% of fund $19.69M
- FBGRX 0.02% of fund $17.10M
- IHE 0.91% of fund $15.61M
- FBTTX 0.64% of fund $15.07M
- NAJ 0.10% of fund $13.75M
- VHT 0.06% of fund $13.12M
Ownership
- Institutions 88.6%
- Insiders 2.52%
- Public and other holders 8.86%
Held by insiders 2.52%
Held by institutions 88.63%
Float held by institutions 90.92%
Institutions 474
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.60% | 11,772,595 | 333.64M | Sep 29, 2026 |
| FMR, LLC | 6.63% | 9,082,203 | 257.39M | Sep 29, 2026 |
| Capital World Investors | 6.03% | 8,255,584 | 233.96M | Sep 29, 2026 |
| Janus Henderson Group Ltd. | 5.26% | 7,196,316 | 203.94M | Sep 29, 2026 |
| Avoro Capital Advisors LLC | 5.15% | 7,050,000 | 199.80M | Sep 29, 2026 |
| Driehaus Capital Management, LLC | 4.96% | 6,788,022 | 192.37M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 7.49% | 10,253,153 | 290.57M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.37% | 3,243,233 | 91.91M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.09% | 1,486,832 | 42.14M | Jun 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.04% | 1,424,929 | 40.38M | Aug 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.94% | 1,287,318 | 36.48M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.86% | 1,170,713 | 33.18M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARROW ROBERT B | Chief Executive Officer | Sale | Sep 24, 2026 | 2,213,090 |
| BRUHN SUZANNE LOUISE | Director | Stock Award(Grant) | Jun 10, 2026 | 24,289 |
| CRYSTAL ROGER | Director | Stock Award(Grant) | Jun 10, 2026 | 24,289 |
| GRYSKA DAVID W | Director | Stock Award(Grant) | Jun 10, 2026 | 19,900 |
| KARLIN DANIEL ROLLINGS | Officer and Director | Sale | Sep 24, 2026 | 792,846 |
| KREBS ANDREAS | Director | Stock Award(Grant) | Jun 10, 2026 | 19,773 |
